PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Virology, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.\', \'Helmholtz Centre for Environmental Research-UFZ, Permoserstraße 15, 04318, Leipzig, Germany.\', \'Center for Applied Geoscience, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.\', \'Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121, Bonn, Germany.\', \'Faculty of Pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000, Ljubljana, Slovenia.\', \'Institute of Inorganic Chemistry, University of Bonn, Gerhard-Domagk-Str. 1, 53121, Bonn, Germany.\', \'German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/cmdc.202100732
?:doi
?:hasPublicationType
?:journal
  • ChemMedChem
is ?:pmid of
?:pmid
?:pmid
  • 35099120
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.137
?:rankingScore_hIndex
  • 88
?:title
  • Andrographolide Derivatives Target the KEAP1/NRF2 Axis and Possess Potent Anti-SARS-CoV-2 Activity.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all